Viking Therapeutics Inc Asset Resilience Ratio

Latest as of June 2026: 72.03%

Viking Therapeutics Inc asset resilience ratio. Viking Therapeutics Inc (VKTX) has an Asset Resilience Ratio of 72.03% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read VKTX liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

$375.91 Million

Cash + Short-term Investments

Total Assets

$521.90 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Viking Therapeutics Inc (2015–2025)

Asset resilience ratio of Viking Therapeutics Inc from 2015 to 2025. This chart shows how Viking Therapeutics Inc's Asset Resilience Ratio has changed over time. See Viking Therapeutics Inc (VKTX) flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Viking Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see VKTX total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$375.91 Million	72.03%
Total Liquid Assets	$375.91 Million	72.03%

Asset Resilience Insights

Very High Liquidity: Viking Therapeutics Inc maintains exceptional liquid asset reserves at 72.03% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Viking Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Viking Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

Viking Therapeutics Inc Asset Resilience Ratio by Year (2015–2025)

Viking Therapeutics Inc asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Viking Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	75.44%	$539.93 Million	$715.73 Million	-21.00pp
2024-12-31	96.43%	$875.94 Million	$908.32 Million	+13.24pp
2023-12-31	83.19%	$306.56 Million	$368.49 Million	+12.67pp
2022-12-31	70.52%	$118.85 Million	$168.53 Million	-12.90pp
2021-12-31	83.42%	$175.73 Million	$210.66 Million	-2.07pp
2020-12-31	85.48%	$219.27 Million	$256.50 Million	-8.54pp
2019-12-31	94.02%	$267.26 Million	$284.26 Million	+2.48pp
2018-12-31	91.54%	$276.74 Million	$302.31 Million	+39.16pp
2017-12-31	52.38%	$11.59 Million	$22.12 Million	-16.93pp
2016-12-31	69.31%	$10.08 Million	$14.54 Million	-17.06pp
2015-12-31	86.37%	$13.34 Million	$15.44 Million	--

pp = percentage points

About Viking Therapeutics Inc

NASDAQ:VKTX USA Biotechnology

Market Cap

$3.47 Billion

Market Cap Rank

#4350 Global

#1529 in USA

Share Price

$27.28

Change (1 day)

+1.56%

52-Week Range

$24.21 - $42.13

All Time High

$94.50